Journal article icon

Journal article

Are IPRs and patents the real barriers to COVID-19 vaccine supplies?

Abstract:

In less than a year since the WHO’s declaration of COVID-19 as a global pandemic, 13 vaccines against COVID-19 have been approved in at least one jurisdiction. However, new challenges have arisen, mostly surrounding the global distribution and access to these vaccines, particularly for low and middle-income countries. The Intellectual Property Rights (IPRs), mainly patents, have been accused of standing in the way of global vaccination supplies.

By adopting an evidence-based approa...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publication website:
https://www.electronicpublications.org/catalogue/107

Authors


More by this author
Institution:
University of Oxford
Division:
SSD
Department:
Law
Sub department:
Law Faculty
Role:
Author
Publisher:
ElectronicPublications.org Ltd
Journal:
Manchester Journal of International Economic Law More from this journal
Volume:
18
Issue:
2
Pages:
192-204
Publication date:
2021-10-07
Acceptance date:
2021-08-23
ISSN:
1742-3945
Language:
English
Keywords:
Pubs id:
1203274
Local pid:
pubs:1203274
Deposit date:
2021-10-18

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP